DARA and PACB.
Biotech acquisition targets.
These are small market cap companies in biotech space that have great growth potential and many catalysts this qtr. Big Pharma should tender offer these before their share prices run away higher IMO.
Q - How would you purchase 50,000 - 100,000 shares of each? Scale in on dips or another method?